BACKGROUND: It is the physicians' task to translate evidence and guidelines into medical strategies for individual patients. Until today, however, there is no formal tool that is instrumental to perform this translation. METHODS: We introduce the analysis of strengths (S) and weaknesses (W) related to therapy with opportunities (O) and threats (T) related to individual patients as a tool to establish an individualized (I) medical strategy (I-SWOT). The I-SWOT matrix identifies four fundamental types of strategy. These comprise "SO" maximizing strengths and opportunities, "WT" minimizing weaknesses and threats, "WO" minimizing weaknesses and maximizing opportunities, and "ST" maximizing strengths and minimizing threats. Each distinct type of strategy may be considered for individualized medical strategies. RESULTS: We describe four steps of I-SWOT to establish an individualized medical strategy to treat aortic disease. In the first step, we define the goal of therapy and identify all evidence-based therapeutic options. In a second step, we assess strengths and weaknesses of each therapeutic option in a SW matrix form. In a third step, we assess opportunities and threats related to the individual patient, and in a final step, we use the I-SWOT matrix to establish an individualized medical strategy through matching "SW" with "OT". As an example we present two 30-year-old patients with Marfan syndrome with identical medical history and aortic pathology. As a result of I-SWOT analysis of their individual opportunities and threats, we identified two distinct medical strategies in these patients. CONCLUSION: I-SWOT is a formal but easy to use tool to translate medical evidence into individualized medical strategies.
BACKGROUND: It is the physicians' task to translate evidence and guidelines into medical strategies for individual patients. Until today, however, there is no formal tool that is instrumental to perform this translation. METHODS: We introduce the analysis of strengths (S) and weaknesses (W) related to therapy with opportunities (O) and threats (T) related to individual patients as a tool to establish an individualized (I) medical strategy (I-SWOT). The I-SWOT matrix identifies four fundamental types of strategy. These comprise "SO" maximizing strengths and opportunities, "WT" minimizing weaknesses and threats, "WO" minimizing weaknesses and maximizing opportunities, and "ST" maximizing strengths and minimizing threats. Each distinct type of strategy may be considered for individualized medical strategies. RESULTS: We describe four steps of I-SWOT to establish an individualized medical strategy to treat aortic disease. In the first step, we define the goal of therapy and identify all evidence-based therapeutic options. In a second step, we assess strengths and weaknesses of each therapeutic option in a SW matrix form. In a third step, we assess opportunities and threats related to the individual patient, and in a final step, we use the I-SWOT matrix to establish an individualized medical strategy through matching "SW" with "OT". As an example we present two 30-year-old patients with Marfan syndrome with identical medical history and aortic pathology. As a result of I-SWOT analysis of their individual opportunities and threats, we identified two distinct medical strategies in these patients. CONCLUSION: I-SWOT is a formal but easy to use tool to translate medical evidence into individualized medical strategies.
Entities:
Keywords:
Aorta; Evidence-based medicine; Medical decision-making; SWOT analysis; Strategy
Authors: Alec Vahanian; Helmut Baumgartner; Jeroen Bax; Eric Butchart; Robert Dion; Gerasimos Filippatos; Frank Flachskampf; Roger Hall; Bernard Iung; Jaroslaw Kasprzak; Patrick Nataf; Pilar Tornos; Lucia Torracca; Arnold Wenink Journal: Eur Heart J Date: 2007-01-26 Impact factor: 29.983
Authors: Raimund Erbel; Victor Aboyans; Catherine Boileau; Eduardo Bossone; Roberto Di Bartolomeo; Holger Eggebrecht; Arturo Evangelista; Volkmar Falk; Herbert Frank; Oliver Gaemperli; Martin Grabenwöger; Axel Haverich; Bernard Iung; Athanasios John Manolis; Folkert Meijboom; Christoph A Nienaber; Marco Roffi; Hervé Rousseau; Udo Sechtem; Per Anton Sirnes; Regula S von Allmen; Christiaan J M Vrints Journal: Eur Heart J Date: 2014-08-29 Impact factor: 29.983
Authors: Lilian J Meijboom; Janneke Timmermans; Aeiko H Zwinderman; Peter M Engelfriet; Barbara J M Mulder Journal: Am J Cardiol Date: 2005-10-05 Impact factor: 2.778
Authors: Tom Treasure; Johanna J M Takkenberg; Tal Golesworthy; Filip Rega; Mario Petrou; Ulrich Rosendahl; Raad Mohiaddin; Michael Rubens; Warren Thornton; Belinda Lees; John Pepper Journal: Heart Date: 2014-01-06 Impact factor: 5.994
Authors: Yskert von Kodolitsch; Meike Rybczynski; Marina Vogler; Thomas S Mir; Helke Schüler; Kerstin Kutsche; Georg Rosenberger; Christian Detter; Alexander M Bernhardt; Axel Larena-Avellaneda; Tilo Kölbel; E Sebastian Debus; Malte Schroeder; Stephan J Linke; Bettina Fuisting; Barbara Napp; Anna Lena Kammal; Klaus Püschel; Peter Bannas; Boris A Hoffmann; Nele Gessler; Eva Vahle-Hinz; Bärbel Kahl-Nieke; Götz Thomalla; Christina Weiler-Normann; Gunda Ohm; Stefan Neumann; Dieter Benninghoven; Stefan Blankenberg; Reed E Pyeritz Journal: J Multidiscip Healthc Date: 2016-11-03
Authors: A Sachweh; Y von Kodolitsch; T Kölbel; A Larena-Avellaneda; S Wipper; A M Bernhardt; E Girdauskas; C Detter; H Reichenspurner; C R Blankart; E S Debus Journal: Gefasschirurgie Date: 2017-02-07
Authors: Youwei Zhu; Na Zhong; Hang Su; Xiaolu Ruan; Jiayi Bao; Lei Zhang; Jiang Du; Ding Xu; Rongjie Ding; Ke Xiao; Min Zhao Journal: Gen Psychiatr Date: 2019-07-16
Authors: Ramón Eizaga Rebollar; María Victoria García Palacios; María Del Carmen Fernández Mangas; Francisco Javier Arroyo Fernández; Carlos Miguel Márquez Rodríguez; Ana Isabel Carnota Martín; Javier Morales Guerrero; Luis Miguel Torres Morera Journal: Pediatr Qual Saf Date: 2020-01-22